How long does follow-up after cancer treatment take to work for lobular carcinoma in situ?

Lobular carcinoma in situ is a finding in breast tissue rather than an invasive cancer. Follow-up may therefore focus on breast awareness, clinical assessment, imaging suited to your personal history, and discussion of risk-reducing options when appropriate. The plan is individual: your age, family history, biopsy details, breast density, and previous procedures may affect what your team recommends. Surveillance provides continuing assessment; it does not remove the need to report a new change.

Attend the breast reviews and imaging appointments arranged for you. Know how your breasts normally look and feel, and report a new lump, nipple change, skin change, discharge, or persistent focal pain. Keep your family and personal history updated with the team. Ask how often reviews are expected, what each examination or scan is intended to assess, and whether a risk-reducing medicine or procedure is relevant to you.

Contact your breast care team promptly if you notice a new or changing lump, nipple inversion, spontaneous discharge, skin dimpling, persistent one-sided pain, or a change near a biopsy or surgical site. Seek urgent help for severe symptoms such as heavy bleeding, collapse, or serious breathing difficulty. These changes can have benign explanations, but a clinician should assess them.

Ask: What does my LCIS finding mean for my personal follow-up plan? Which breast checks are recommended? What changes should I report promptly? How will imaging results be explained? Should we discuss family history, genetic counselling, or risk-reducing options?